Metadichol® Approved Patent Claims


US Patent No. US 8,722,093 B2

  • A method of increasing serum vitamin C level in a subject
  • A method of inhibiting NF-κB protein level in a subject
  • A method of increasing adiponectin level in a subject
  • A method of reducing TNF alpha level in a subject

US Patent No. US 9,006,292 B2
  • A method of treating a skin disease in a subject, comprising: psoriasis, atopic dermatitis, contact dermatitis and other eczematous dermatitis’s, seborrhoeic dermatitis, neurodermatitis, decubitus, lichen planus, pemphigus, bullate pemphigoid, epidermolysis bullosa, urticaria, angioedemas, vasculitides, erythema, cutaneous, eosinophilias, lupus erythematosuseczema, and MRSA, basal cell carcinoma
  • A method of treating a disease by improving a physiologic or metabolic parameter in a subject. The said method comprising: Increasing serum APO A1 protein, hemoglobin, platelet count; Reducing lipoprotein-a, uric acid, elevated AST:ALT ratio, ferritin, bilirubin, PTH, calcium, creatinine, alkaline phosphatase, BUN, phosphorus levels;
    Regulating eGFR level, neutrophils, monocytes, white blood cell, thyroid hormone (TSH).
  • The method of claim wherein said disease is: kidney disease, MRSA infection, MDS, hematological disease, prostate cancer, and eczema.